Industry insights indicate that the Global Vascular Closure Equipment Market was valued at approximately USD 2.10 billion in 2025 and is projected to reach a valuation of USD 4.85 billion by the year 2036, expanding at a compound annual growth rate (CAGR) of 7.9% during the forecast period.
Global Vascular Closure Equipment Market Overview
The 2025 Global Vascular Closure Equipment Market report provides a detailed examination of the shift from traditional manual compression to advanced mechanical and chemical closure systems. Vascular closure devices (VCDs) are engineered to achieve rapid hemostasis at the arterial or venous access site following catheterization. This research integrates historical data (2020–2024) to forecast adoption rates through 2036, focusing on the miniaturization of devices and the rising demand for large-bore closure solutions necessitated by complex structural heart procedures.
Post-Pandemic Clinical Landscape
The COVID-19 pandemic caused a temporary downturn in the vascular closure market during 2020 as elective cardiovascular procedures were deferred to conserve hospital resources. However, the subsequent "backlog recovery" and a permanent shift toward Ambulatory Surgical Centers (ASCs) have accelerated market growth. Modern clinical settings now prioritize VCDs to facilitate "same-day discharge" protocols, minimizing hospital stays and reducing the risk of nosocomial infections.
Segments Analysis
By Access Site (New Segment):
-
Femoral Access: The traditional gold standard, particularly for large-bore procedures like TAVI and EVAR.
-
Radial Access: The fastest-growing segment, driven by lower complication rates and improved patient mobility post-procedure.
By Mechanism/Type:
-
Active Approximators: Suture-mediated and clip-based devices that physically close the arteriotomy.
-
Passive Approximators: Collagen plugs, sealant-based systems, and compression-assisted devices that promote natural clotting.
-
External Hemostatic Devices: Patches, pads, and pressure bandages integrated with procoagulant agents.
By Application:
-
Interventional Cardiology: Diagnostic angiograms and therapeutic angioplasty/stenting.
-
Interventional Radiology: Peripheral vascular interventions and oncology-related catheterization.
-
Structural Heart Procedures: High-value segment focusing on transcatheter valve replacements.
By End-User:
-
Hospitals & Cardiac Centers
-
Ambulatory Surgical Centers (ASCs)
-
Specialized Vascular Clinics
Regional Analysis
-
North America: Commands the largest share (~40%) due to high per-capita healthcare spending, a high volume of cardiac catheterizations, and rapid adoption of the latest "large-bore" closure technologies.
-
Europe: A mature market characterized by robust clinical research and a high preference for suture-mediated closure in Germany, France, and the UK.
-
Asia-Pacific: Anticipated to witness the highest CAGR through 2036. Growth is fueled by an aging population in Japan and China, coupled with expanding specialized cardiovascular infrastructure in India and Southeast Asia.
-
LAMEA: Increasing surgical volumes in the Middle East and improving medical reimbursement frameworks in Brazil are driving steady expansion.
Top Key Players
-
Market Dominators: Abbott Laboratories, Terumo Corporation (Vascade), Teleflex Incorporated, Cardinal Health (Cordis).
-
Specialized Medical Tech: Merit Medical Systems, Haemonetics Corporation, Vivasure Medical, Vasorum Ltd.
-
Innovative Disruptors: InSeal Medical, Vivasure Medical, Morrris Innovative, Transluminal Technologies, Medeon Biodesign.
-
Regional Powerhouses: Beijing Puyishengji Medical Technology, Endocor, Essential Medical (acquired by Teleflex).
Porter’s Five Forces Analysis
-
Threat of New Entrants (Low): Stringent FDA/CE Class III clinical trial requirements and massive R&D costs create high entry barriers.
-
Bargaining Power of Buyers (High): Hospital networks and GPOs (Group Purchasing Organizations) exert significant pressure on per-unit pricing.
-
Bargaining Power of Suppliers (Moderate): Suppliers of biocompatible polymers and medical-grade nitinol maintain steady influence.
-
Threat of Substitutes (Moderate): Manual compression remains a low-cost alternative, although it is increasingly viewed as inefficient for high-volume labs.
-
Competitive Rivalry (Intense): Intense competition between Abbott and Terumo for dominance in the "StarClose" and "Angio-Seal" categories.
SWOT Analysis
-
Strengths: Drastic reduction in "time-to-ambulation"; improved patient satisfaction; high recurring revenue from single-use disposables.
-
Weaknesses: High cost per procedure; potential for rare but serious complications (e.g., limb ischemia or infection).
-
Opportunities: The rise of Large-Bore VCDs for transcatheter procedures; expansion into emerging APAC markets.
-
Threats: Physician preference for manual compression in certain radial access cases; potential for price erosion due to generic competition in basic patches.
Trend Analysis
-
The Large-Bore Revolution: Development of specialized closure devices for 14F to 24F sheaths used in TAVI and TEVAR.
-
Bio-resorbable Components: A shift toward devices that leave no permanent metal or synthetic footprint in the artery.
-
Automation: Integrated deployment systems that minimize "operator dependency," ensuring consistent results regardless of the surgeon's experience level.
Drivers & Challenges
-
Driver: The global "silver tsunami"—an aging population with a high prevalence of coronary and peripheral artery diseases.
-
Driver: Preference for minimally invasive surgeries that reduce hospital stay duration and overall healthcare costs.
-
Challenge: Ensuring device safety in patients with highly calcified or diseased arteries.
-
Challenge: Significant training curve required for complex suture-mediated devices to prevent procedural failure.
Value Chain Analysis
-
R&D: Focusing on biocompatibility, tensile strength, and ultra-low profile delivery systems.
-
Manufacturing: High-precision assembly in ISO-certified cleanrooms.
-
Regulatory: Navigating complex PMA (Pre-Market Approval) and MDR (Medical Device Regulation) pathways.
-
Sales & Distribution: Direct sales teams providing on-site clinical support to interventionalists.
-
Post-Market Surveillance: Continuous data collection on long-term patient outcomes and device integrity.
Quick Recommendations for Stakeholders
-
For Manufacturers: Prioritize the development of Universal Access Devices that can handle both standard and large-bore closures with a single platform.
-
For Investors: Target the Radial Closure and ASC-specialized segments, as outpatient catheterization is the fastest-growing volume driver.
-
For Healthcare Providers: Transition to standardized VCD protocols for diagnostic cases to increase lab throughput and reduce recovery-room staffing costs.
-
For R&D Teams: Focus on fully absorbable suture/plug technology to cater to the growing clinical demand for "nothing left behind" interventional outcomes.
1. Market Overview of Vascular Closure Equipment
1.1 Vascular Closure Equipment Market Overview
1.1.1 Vascular Closure Equipment Product Scope
1.1.2 Market Status and Outlook
1.2 Vascular Closure Equipment Market Size by Regions:
1.3 Vascular Closure Equipment Historic Market Size by Regions
1.4 Vascular Closure Equipment Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Vascular Closure Equipment Sales Market by Type
2.1 Global Vascular Closure Equipment Historic Market Size by Type
2.2 Global Vascular Closure Equipment Forecasted Market Size by Type
2.3 Active Approximators
2.4 Passive Approximators
3. Covid-19 Impact Vascular Closure Equipment Sales Market by Application
3.1 Global Vascular Closure Equipment Historic Market Size by Application
3.2 Global Vascular Closure Equipment Forecasted Market Size by Application
3.3 Diagnostic Intervention
3.4 Therapeutic Intervention
3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Vascular Closure Equipment Production Capacity Market Share by Manufacturers
4.2 Global Vascular Closure Equipment Revenue Market Share by Manufacturers
4.3 Global Vascular Closure Equipment Average Price by Manufacturers
5. Company Profiles and Key Figures in Vascular Closure Equipment Business
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Company Profile
5.1.2 Abbott Laboratories Vascular Closure Equipment Product Specification
5.1.3 Abbott Laboratories Vascular Closure Equipment Production Capacity, Revenue, Price and Gross Margin
5.2 Cardinal Health
5.2.1 Cardinal Health Company Profile
5.2.2 Cardinal Health Vascular Closure Equipment Product Specification
5.2.3 Cardinal Health Vascular Closure Equipment Production Capacity, Revenue, Price and Gross Margin
5.3 St. Jude Medical
5.3.1 St. Jude Medical Company Profile
5.3.2 St. Jude Medical Vascular Closure Equipment Product Specification
5.3.3 St. Jude Medical Vascular Closure Equipment Production Capacity, Revenue, Price and Gross Margin
5.4 Vascular Solutions
5.4.1 Vascular Solutions Company Profile
5.4.2 Vascular Solutions Vascular Closure Equipment Product Specification
5.4.3 Vascular Solutions Vascular Closure Equipment Production Capacity, Revenue, Price and Gross Margin
5.5 Arstasis
5.5.1 Arstasis Company Profile
5.5.2 Arstasis Vascular Closure Equipment Product Specification
5.5.3 Arstasis Vascular Closure Equipment Production Capacity, Revenue, Price and Gross Margin
5.6 Beijing Puyishengji Medical Technology
5.6.1 Beijing Puyishengji Medical Technology Company Profile
5.6.2 Beijing Puyishengji Medical Technology Vascular Closure Equipment Product Specification
5.6.3 Beijing Puyishengji Medical Technology Vascular Closure Equipment Production Capacity, Revenue, Price and Gross Margin
5.7 Endocor
5.7.1 Endocor Company Profile
5.7.2 Endocor Vascular Closure Equipment Product Specification
5.7.3 Endocor Vascular Closure Equipment Production Capacity, Revenue, Price and Gross Margin
5.8 Essential Medical
5.8.1 Essential Medical Company Profile
5.8.2 Essential Medical Vascular Closure Equipment Product Specification
5.8.3 Essential Medical Vascular Closure Equipment Production Capacity, Revenue, Price and Gross Margin
5.9 InSeal Medical
5.9.1 InSeal Medical Company Profile
5.9.2 InSeal Medical Vascular Closure Equipment Product Specification
5.9.3 InSeal Medical Vascular Closure Equipment Production Capacity, Revenue, Price and Gross Margin
5.10 Medeon Biodesign
5.10.1 Medeon Biodesign Company Profile
5.10.2 Medeon Biodesign Vascular Closure Equipment Product Specification
5.10.3 Medeon Biodesign Vascular Closure Equipment Production Capacity, Revenue, Price and Gross Margin
5.11 Morrris Innovative
5.11.1 Morrris Innovative Company Profile
5.11.2 Morrris Innovative Vascular Closure Equipment Product Specification
5.11.3 Morrris Innovative Vascular Closure Equipment Production Capacity, Revenue, Price and Gross Margin
5.12 Transluminal Technologies
5.12.1 Transluminal Technologies Company Profile
5.12.2 Transluminal Technologies Vascular Closure Equipment Product Specification
5.12.3 Transluminal Technologies Vascular Closure Equipment Production Capacity, Revenue, Price and Gross Margin
5.13 Vasorum
5.13.1 Vasorum Company Profile
5.13.2 Vasorum Vascular Closure Equipment Product Specification
5.13.3 Vasorum Vascular Closure Equipment Production Capacity, Revenue, Price and Gross Margin
5.14 Vivasure Medical
5.14.1 Vivasure Medical Company Profile
5.14.2 Vivasure Medical Vascular Closure Equipment Product Specification
5.14.3 Vivasure Medical Vascular Closure Equipment Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Vascular Closure Equipment Market Size
6.2 North America Vascular Closure Equipment Key Players in North America
6.3 North America Vascular Closure Equipment Market Size by Type
6.4 North America Vascular Closure Equipment Market Size by Application
7. East Asia
7.1 East Asia Vascular Closure Equipment Market Size
7.2 East Asia Vascular Closure Equipment Key Players in North America
7.3 East Asia Vascular Closure Equipment Market Size by Type
7.4 East Asia Vascular Closure Equipment Market Size by Application
8. Europe
8.1 Europe Vascular Closure Equipment Market Size
8.2 Europe Vascular Closure Equipment Key Players in North America
8.3 Europe Vascular Closure Equipment Market Size by Type
8.4 Europe Vascular Closure Equipment Market Size by Application
9. South Asia
9.1 South Asia Vascular Closure Equipment Market Size
9.2 South Asia Vascular Closure Equipment Key Players in North America
9.3 South Asia Vascular Closure Equipment Market Size by Type
9.4 South Asia Vascular Closure Equipment Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Vascular Closure Equipment Market Size
10.2 Southeast Asia Vascular Closure Equipment Key Players in North America
10.3 Southeast Asia Vascular Closure Equipment Market Size by Type
10.4 Southeast Asia Vascular Closure Equipment Market Size by Application
11. Middle East
11.1 Middle East Vascular Closure Equipment Market Size
11.2 Middle East Vascular Closure Equipment Key Players in North America
11.3 Middle East Vascular Closure Equipment Market Size by Type
11.4 Middle East Vascular Closure Equipment Market Size by Application
12. Africa
12.1 Africa Vascular Closure Equipment Market Size
12.2 Africa Vascular Closure Equipment Key Players in North America
12.3 Africa Vascular Closure Equipment Market Size by Type
12.4 Africa Vascular Closure Equipment Market Size by Application
13. Oceania
13.1 Oceania Vascular Closure Equipment Market Size
13.2 Oceania Vascular Closure Equipment Key Players in North America
13.3 Oceania Vascular Closure Equipment Market Size by Type
13.4 Oceania Vascular Closure Equipment Market Size by Application
14. South America
14.1 South America Vascular Closure Equipment Market Size
14.2 South America Vascular Closure Equipment Key Players in North America
14.3 South America Vascular Closure Equipment Market Size by Type
14.4 South America Vascular Closure Equipment Market Size by Application
15. Rest of the World
15.1 Rest of the World Vascular Closure Equipment Market Size
15.2 Rest of the World Vascular Closure Equipment Key Players in North America
15.3 Rest of the World Vascular Closure Equipment Market Size by Type
15.4 Rest of the World Vascular Closure Equipment Market Size by Application
16 Vascular Closure Equipment Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Segments Analysis
By Access Site (New Segment):
-
Femoral Access: The traditional gold standard, particularly for large-bore procedures like TAVI and EVAR.
-
Radial Access: The fastest-growing segment, driven by lower complication rates and improved patient mobility post-procedure.
By Mechanism/Type:
-
Active Approximators: Suture-mediated and clip-based devices that physically close the arteriotomy.
-
Passive Approximators: Collagen plugs, sealant-based systems, and compression-assisted devices that promote natural clotting.
-
External Hemostatic Devices: Patches, pads, and pressure bandages integrated with procoagulant agents.
By Application:
-
Interventional Cardiology: Diagnostic angiograms and therapeutic angioplasty/stenting.
-
Interventional Radiology: Peripheral vascular interventions and oncology-related catheterization.
-
Structural Heart Procedures: High-value segment focusing on transcatheter valve replacements.
By End-User:
-
Hospitals & Cardiac Centers
-
Ambulatory Surgical Centers (ASCs)
-
Specialized Vascular Clinics
Regional Analysis
-
North America: Commands the largest share (~40%) due to high per-capita healthcare spending, a high volume of cardiac catheterizations, and rapid adoption of the latest "large-bore" closure technologies.
-
Europe: A mature market characterized by robust clinical research and a high preference for suture-mediated closure in Germany, France, and the UK.
-
Asia-Pacific: Anticipated to witness the highest CAGR through 2036. Growth is fueled by an aging population in Japan and China, coupled with expanding specialized cardiovascular infrastructure in India and Southeast Asia.
-
LAMEA: Increasing surgical volumes in the Middle East and improving medical reimbursement frameworks in Brazil are driving steady expansion.
Top Key Players
-
Market Dominators: Abbott Laboratories, Terumo Corporation (Vascade), Teleflex Incorporated, Cardinal Health (Cordis).
-
Specialized Medical Tech: Merit Medical Systems, Haemonetics Corporation, Vivasure Medical, Vasorum Ltd.
-
Innovative Disruptors: InSeal Medical, Vivasure Medical, Morrris Innovative, Transluminal Technologies, Medeon Biodesign.
-
Regional Powerhouses: Beijing Puyishengji Medical Technology, Endocor, Essential Medical (acquired by Teleflex).
